Effects of laparoscopic ovarian drilling in treating infertile anovulatory polycystic ovarian syndrome patients with and without metabolic syndrome

Hong Kong Medical Journal

Volumn 17, Issue 1, 2011, Pages 5-10

  Kong, Grace W S ^a   Cheung, L P ^a   Lok, Ingrid H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diabetes mellitus; Female; Hyperandrogenism; Infertility; Metabolic syndrome X; Polycystic ovary syndrome; Type 2

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ANOVULATION; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLOW UP; HONG KONG; HUMAN; HYPERTENSION; INTRAUTERINE INSEMINATION; LAPAROSCOPIC OVARIAN DRILLING; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MULTIPLE CYCLE TREATMENT; OBESITY; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION;

ADULT; FEMALE; HUMANS; INFERTILITY, FEMALE; LAPAROSCOPY; METABOLIC SYNDROME X; OVULATION; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES;

EID: 79951481388     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Farah L, Lazenby AJ, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med 1999;44:870-4.
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-9.
3. Brassard M, AinMelk Y, Baillargeon JP. Basic infertility including polycystic ovary syndrome. Med Clin North Am 2008;92:1163-92,xi.
4. Beck JI, Boothroyd C, Proctor M, Farquhar C, Hughes E. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 2005;(1):CD002249.
5. National Collaborating Centre for Women's and Children's Health / National Institute for Clinical Excellence. Fertility: assessment and treatment for people with fertility problem. RCOG Press; 2004.
6. Li TC, Saravelos H, Chow MS, Chisabingo R, Cooke ID. Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br J Obstet Gynaecol 1998;105:338-44.
7. Nestler JE. Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications. Semin Reprod Endocrinol 1997;15:111-22.
8. Poretsky L, Piper B. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol 1994;84:613-21.
9. Hopkinson ZE, Sattar N, Fleming R, Greer IA. Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology. BMJ 1998;317:329-32.
10. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141-6.
11. Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod 2006;21:2027-32.
12. Sartor BM, Dickey RP. Polycystic ovarian syndrome and the metabolic syndrome. Am J Med Sci 2005;330:336-42.
13. Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106:131-7.
14. Dahlgren E, Johansson S, Lindstedt G, et al. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 1992;57:505-13.
15. Cheung LP, Ma RC, Lam PM, et al. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome. Hum Reprod 2008;23:1431-8.
16. Amer SA, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Hum Reprod 2004;19:1719-24.
17. Tulandi T, Saleh A, Morris D, Jacobs HS, Payne NN, Tan SL. Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome. Fertil Steril 2000;74:585-8.
18. Lemieux S, Lewis GF, Ben-Chetrit A, Steiner G, Greenblatt EM. Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipidlipoprotein levels. J Clin Endocrinol Metab 1999;84:4278-82.
19. Tiitinen A, Tenhunen A, Seppälä M. Ovarian electrocauterization causes LH-regulated but not insulinregulated endocrine changes. Clin Endocrinol (Oxf) 1993;39:181-4.
20. Duleba AJ, Banaszewska B, Spaczynski RZ, Pawelczyk L. Success of laparoscopic ovarian wedge resection is related to obesity, lipid profile, and insulin levels. Fertil Steril 2003;79:1008-14.
21. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
22. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
23. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
24. World Health Organization, International Association for the Study of Obesity, International Obesity Taskforce. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications; 2000.
25. Lam PM, Tam WH, Cheung LP. Higher metabolic risk in Chinese women fulfilling the NIH diagnostic criteria for polycystic ovarian syndrome. Fertil Steril 2009;91:1493-5.
26. Leon S, Robert HG, Nathan GK. Clinical gynecologic endocrinology and infertility. 6th ed. Baltimore: Lippincott Williams & Wilkins; 1999.
27. Martin FI, The diagnosis of gestational diabetes. Ad Hoc Working Party. Med J Aust 1991;155:112.
28. Vrbíková J, Vondra K, Cibula D, et al. Metabolic syndrome in young Czech women with polycystic ovary syndrome. Hum Reprod 2005;20:3328-32.
29. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 2006;154:141-5.
30. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1929-35.
31. Haffner SM. The insulin resistance syndrome revisited. Diabetes Care 1996;19:275-7.
32. Greenblatt E. Surgical options in polycystic ovary syndrome patients who do not respond to medical ovulation induction. Bailliere Clin Obstet Gynaecol 1993;7:421-33.
33. Palomba S, Falbo A, Orio F, Zullo F. Insulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients. Curr Opin Obstet Gynecol 2008;20:364-73.
34. Palomba S, Orio F Jr, Nardo LG, et al. Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized doubleblind placebo-controlled trial. J Clin Endocrinol Metab 2004;89:4801-9.